 |
|
Testosterone Replacement Therapy (TRT) Beneficial In Men 60 And Older
April 08, 2008New study finds testosterone injections improve bone density markers in older men; first known study to report on the impact of bone metabolism based on dosing regimen
SAN DIEGO, CA - The risk of osteoporosis (bone fracture) in women is highly recognized by the public. Less appreciated is the fact that the disorder also occurs in men. Some two million males have been diagnosed with osteoporosis and another three million are at risk.
Gender-based hormones and age are thought to be major factors behind bone fractures in both sexes. Women with low levels of estrogen and men with low levels of the testosterone are known to be at risk. Low levels of gender hormones can lead to diminished bone mineral density (BMD; also known as bone mass). Reduced bone density or bone mass means there is less cushioning to protect the bone from cracking in a slip or fall.
For this reason, testosterone replacement therapy (TRT) is the standard of care used to improve bone strength and muscle mass in males. However, TRT use has been the subject of some controversy. Continuous testosterone use has been associated with prostate cancer and high red blood cell levels, and its other effects are not fully known.
In one of the first clinical trials involving men over 60-85 years of age, researchers' preliminary results indicate that testosterone treatment for five months has a positive effect on the bone markers of older men. This is the first known study to report on the impact of bone metabolism based on dosing schedules.
Presentation at the 121st Annual Meeting of the American Physiological Society
The study was conducted by E. Lichar Dillon, Randall J. Urban, James A. Angel, Shanon L. Casperson and Melinda Sheffield-Moore, all of the Department of Internal Medicine, University of Texas Medical Branch, Galveston, TX; and Douglas Paddon-Jones of the Department of Rehabilitation Sciences and Physical Therapy, the University of Texas Medical Branch. Their study was funded in part by the National Institutes of Health (NIH) and is entitled Continuous Testosterone Administration for Five Months Reduces Markers of Bone Turnover in Older Men. Dr. Dillon is presenting the team's preliminary findings at the 121st Annual Meeting of the American Physiological Society (APS; www.the-APS.org/press), part of the Experimental Biology 2008 scientific conference.
Study Summary
Thirteen older men between 60 - 85 years have thusfar participated in the study. Testosterone levels ranged between 200-500 nanograms (ng) of testosterone per deciliter of blood (dL) at the time of enrollment. (Normal limits are considered 250-800.) Each was enrolled in one of three double-blinded groups: (1) those receiving continuous weekly intramuscular injections of testosterone (100 mg testosterone-enanthate) for the entire five month period (TE; n=4); (2) those receiving weekly testosterone every other month (one month of weekly testosterone/one month of weekly placebo; MO; n=4); or (3) those receiving a weekly placebo for the entire five month period (PL; n=5).
The participants visited the clinic weekly for either scheduled treatment injections or placebos. Volunteers received a baseline whole-body Dual Energy X-Ray Absorptiometry (DEXA) scan at the beginning and end of the study. Dietary records were obtained and analyzed at month zero, month three and month five. Fasting blood samples were collected at regular intervals throughout the study to examine serum markers of bone metabolism.
The Preliminary Study Results
The research team found that:
* testosterone administration appears to reduce bone turnover, perhaps closing the gap between resorption and formation
* thusfar, the impact on bone mineral density are unclear but may become more apparent as the study progresses.
* the effects of testosterone on long-term bone metabolism are unclear, but are expected to have at least a protective effect on existing bone mass over time by preventing unwanted increases in bone turnover that are frequently associated with osteoporosis. Osteoporosis is often associated with high bone turnover (increases in bone resorption as well as in bone formation) which results in decreased BMD.
Conclusions
According to Dr. Dillon, the study's first author, "These preliminary data show beneficial effects of testosterone therapy on bone turnover markers in older men with low-to-normal testosterone concentrations using both continuous and monthly cycled testosterone replacement." He added, "The effects of sex hormones on markers of bone formation are complex, but this is an important step in understanding how the process works."
The American Physiological Society (APS)
For this reason, testosterone replacement therapy (TRT) is the standard of care used to improve bone strength and muscle mass in males. However, TRT use has been the subject of some controversy. Continuous testosterone use has been associated with prostate cancer and high red blood cell levels, and its other effects are not fully known.
In one of the first clinical trials involving men over 60-85 years of age, researchers' preliminary results indicate that testosterone treatment for five months has a positive effect on the bone markers of older men. This is the first known study to report on the impact of bone metabolism based on dosing schedules.
Presentation at the 121st Annual Meeting of the American Physiological Society
The study was conducted by E. Lichar Dillon, Randall J. Urban, James A. Angel, Shanon L. Casperson and Melinda Sheffield-Moore, all of the Department of Internal Medicine, University of Texas Medical Branch, Galveston, TX; and Douglas Paddon-Jones of the Department of Rehabilitation Sciences and Physical Therapy, the University of Texas Medical Branch. Their study was funded in part by the National Institutes of Health (NIH) and is entitled Continuous Testosterone Administration for Five Months Reduces Markers of Bone Turnover in Older Men. Dr. Dillon is presenting the team's preliminary findings at the 121st Annual Meeting of the American Physiological Society (APS; www.the-APS.org/press), part of the Experimental Biology 2008 scientific conference.
Study Summary
Thirteen older men between 60 - 85 years have thusfar participated in the study. Testosterone levels ranged between 200-500 nanograms (ng) of testosterone per deciliter of blood (dL) at the time of enrollment. (Normal limits are considered 250-800.) Each was enrolled in one of three double-blinded groups: (1) those receiving continuous weekly intramuscular injections of testosterone (100 mg testosterone-enanthate) for the entire five month period (TE; n=4); (2) those receiving weekly testosterone every other month (one month of weekly testosterone/one month of weekly placebo; MO; n=4); or (3) those receiving a weekly placebo for the entire five month period (PL; n=5).
The participants visited the clinic weekly for either scheduled treatment injections or placebos. Volunteers received a baseline whole-body Dual Energy X-Ray Absorptiometry (DEXA) scan at the beginning and end of the study. Dietary records were obtained and analyzed at month zero, month three and month five. Fasting blood samples were collected at regular intervals throughout the study to examine serum markers of bone metabolism.
The Preliminary Study Results
The research team found that:
* testosterone administration appears to reduce bone turnover, perhaps closing the gap between resorption and formation
* thusfar, the impact on bone mineral density are unclear but may become more apparent as the study progresses.
* the effects of testosterone on long-term bone metabolism are unclear, but are expected to have at least a protective effect on existing bone mass over time by preventing unwanted increases in bone turnover that are frequently associated with osteoporosis. Osteoporosis is often associated with high bone turnover (increases in bone resorption as well as in bone formation) which results in decreased BMD.
Conclusions
According to Dr. Dillon, the study's first author, "These preliminary data show beneficial effects of testosterone therapy on bone turnover markers in older men with low-to-normal testosterone concentrations using both continuous and monthly cycled testosterone replacement." He added, "The effects of sex hormones on markers of bone formation are complex, but this is an important step in understanding how the process works."
The American Physiological Society (APS)
Testosterone Replacement Therapy: How Safe For Aging Men?
For decades, older women have taken hormone replacements to replenish estrogen and progesterone levels lost to aging. More recently, testosterone (the most important male hormone) supplements have been used by aging men to improve their muscle mass, bone strength, libido and quality of life.
No link between short-term testosterone use and prostate cancer, study says
Testosterone therapy does not cause adverse effects on the prostate in older men with hypogonadism, commonly known as low testosterone or low T, according to a clinical trial presented today at a national urology meeting in Atlanta.
Testosterone therapy may help elderly men with mild Alzheimer's disease
Testosterone replacement therapy may help improve the quality of life for elderly men with mild cases of Alzheimer's disease.
More Testosterone Replacement Therapy Current Events and Testosterone Replacement Therapy News Articles
 |
Testosterone for Life: Recharge Your Vitality, Sex Drive, Muscle Mass, and Overall Health by Abraham Morgentaler (Author) "Dr. Morgentaler, an internationally recognized expert in sexual medicine and male hormones, shares his secrets for a healthy life." "A highly valuable resource. Finally debunks many of the myths about testosterone's safety, which has been an impediment to its appropriate usage for far too long." From a Harvard doctor and a leading expert on testosterone--the groundbreaking book that shows you how to raise your testosterone levels--and live your life to the fullest Better sex. Increased vitality. More muscle. Improved health.... |
 |
Testosterone Replacement Therapy: Is it Right For you? The Testosterone Replacement Therapy (TRT) program discusses a problem that for years had been considered a natural and inevitable part of the aging process for men. But today, men don't have to feel ashamed and hide their private suffering. TRT can not only bring vitality and passion back to life for the millions suffering from it, but as research is beginning to support, treating low testosterone levels may actually have a positive benefit on other serious medical conditions like diabetes and heart disease. This product is manufactured on demand using DVD-R recordable media. Amazon.com's standard return policy will apply. |
 |
Maca 500 - 90 Capsules - Peruvian Maca for Hormonal Balance, Sexual Enhancement, Energy Boost by AB Marketers LLC Maca is a root which has much higher concentration of proteins than any other roots of its size. Besides, maca contains great concentrations of iron and calcium and many other important minerals and nutrients. That is the reason why, nutritionists judge it as a vegetable with enormous energy value. Maca root has been used for centuries in the Andean culture. In fact, ancient Andeans have used it as the best natural nutrient and energizer because it enhances the mind and body of anyone who takes it. Besides, Maca 500™ contains greater amounts of glucosinolates compared to all the other maca formulas available in America or Peru. Peruvian Maca is well-recognized to relieve menopause symptoms, stimulate the hormonal balance and ovulation problems in women and improves sperm production in... |
 |
Impression on Life -- Make a lasting impression on life... A conversation about Testoderm TTS -- For replacement therapy in testosterone-deficient men -- VHS Tape Impression on Life -- Make a lasting impression on life... A conversation about Testoderm TTS -- For replacement therapy in testosterone-deficient men -- VHS Tape |
 |
Testosterone Replacement Therapy: Is it Right For you? Directed By: (c) Information Television Network |
 |
ZMA-Primaforce Testosterone Boosting Formula , 360 Vegitarian Capsules (2 Pack) by Primaforce |
 |
Testosterone Deficiency in Men (Oxford Endocrinology Library) by Hugh Jones (Editor) Over the last few years there has been a substantial increase in the interest not only by the medical profession but also the media in the role of testosterone in health and disease. This interest has been mirrored by a rapid increase in research publications and development of improved modes of delivery of testosterone therapy. This new pocketbook provides a comprehensive but concise and up-to-date knowledge of established and salient new data on the management of testosterone deficiency. It includes a background of essential knowledge on the diagnosis, treatment and safety. It also explores the associations of testosterone deficiency with organ systems and their diseases such as diabetes and osteoporosis. |
 |
Testosterone and Aging: Clinical Research Directions by Committee on Assessing the Need for Clinical Trials of Testosterone Replacement Therapy (Author), Catharyn T. Liverman (Editor), Dan G. Blazer (Editor) Text features a report from the National Institute of Medicine, as requested by the National Institute of Aging and the National Cancer Institute, on the potential beneficial and adverse effects of testosterone therapy in older men. Features conclusions and recommendations derived from a twelve-month study and clinical trials. Softcover. |
 |
The Younger You® Testosterone Balance (1 oz.) by The American Health Institute, Inc. To enhance the body's receptivity to bio-identical testosterone, in order to restore hormonal balance, and prevent toxicity from too high of a dose of testosterone. Bottle contains 1 oz. |
|
Testosterone Replacement Therapy by Fred C. Wu (Author) Manchester, U.K. Proceedings of a Satellite Symposium on Testosterone Replacement Therapy held at the 15th Joint Meeting of the British Endocrine Societies in Dublin, Ireland on March 25, 1996. Discusses the longconsequences and short-term of androgen deficiency. 5 contributors, 2 U.S. Softcover. |
| © 2009 BrightSurf.com |